- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: CKD-379(Empagliflozin sitagliptin metformin) Reference drug
Total 442 results
-
The Wistar InstituteNational Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp... and other collaboratorsUnknown
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Mexico, Peru, Russian Federation, United Kingdom, Philippines, South Africa, Spain, Hong Kong, Albania
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes Mellitus (T2DM)United States
-
Dexa Medica GroupCompletedMetformin XR BE Study in Healthy Volunteers With Single and Multiple DoseIndonesia
-
Boehringer IngelheimCompleted
-
Mackay Memorial HospitalUnknown
-
Bio-innova Co., LtdNot yet recruiting
-
AstraZenecaAstraZeneca, Bristol-Myers SquibbCompletedType 2 DiabetesChina, Korea, Republic of, Taiwan, India
-
Boehringer IngelheimCompleted
-
AstraZenecaCompletedType 2 Diabetes MellitusIndia
-
Michael A. NauckCompleted
-
Nanjing First Hospital, Nanjing Medical UniversityNot yet recruitingInsulin Resistance | Type2diabetes
-
Research Clinical Centre of the Russian Railways...UnknownDiabetes Mellitus | Hypoglycemic EpisodesRussian Federation
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesCzech Republic, Korea, Republic of, Hungary, Poland, Ukraine, Philippines, Thailand
-
GL Pharm Tech CorporationCompletedHealthyKorea, Republic of
-
GL Pharm Tech CorporationCompletedHealthyKorea, Republic of
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Poland, Colombia, Mexico, Portugal, Bulgaria, India, Malaysia, Turkey, Ukraine, Greece, Sweden, Singapore, Czech Republic, Argentina, Puerto Rico, Russian Federation, Thailand, Slovakia, Latvia, Estonia, Peru
-
Boehringer IngelheimEli Lilly and CompanyWithdrawnDiabetes Mellitus, Type 2
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type II
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, France, Switzerland, Germany, South Africa, Korea, Republic of, Puerto Rico, Canada, Taiwan, Spain, Poland, Slovakia, Thailand, Mexico, Turkey, Australia, Greece, Norway, Sweden, Peru, Romania, Argentina, United Kingdom
-
Riverside Pharmacueticals CorporationCompleted
-
Boehringer IngelheimCompleted
-
Population Health Research InstituteAstraZenecaCompletedType 2 Diabetes MellitusCanada
-
AstraZenecaAstraZeneca, Bristol-Myers SquibbCompletedType 2 DiabetesChina, Korea, Republic of, India
-
Khoo Teck Puat HospitalCompletedType II Diabetes in Subjects BMI 27 to 32Singapore
-
Chungbuk National University HospitalCompleted
-
AstraZenecaCompletedSaxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseDiabetes Mellitus, Type 2United States, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
Shandong Provincial HospitalChinese Medical AssociationUnknown
-
Novo Nordisk A/SWithdrawnDiabetes Mellitus, Type 2Thailand, Malaysia, Poland, India, Hungary, Mexico, Brazil, United States, Croatia, Romania, Bulgaria, Greece, Serbia
-
Eli Lilly and CompanyTerminatedDiabetes Mellitus, Type 2United States, Puerto Rico, Greece, Taiwan
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, France, Germany, Greece, India, Ireland, Japan, Korea, Republic of, Mexico, Philippines, Slovakia, Slovenia, Switzerland, Taiwan, Turkey, Ukraine
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Czech Republic, Estonia, Finland, France, Germany, Hungary, Latvia, Norway, Romania, Russian Federation, Slovakia, Spain, Ukraine
-
Boehringer IngelheimCompleted
-
University Hospital, Gentofte, CopenhagenEli Lilly and CompanyCompleted
-
Boehringer IngelheimCompleted
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic ControlUnited States, Canada, Czechia, Germany, Russian Federation, Mexico
-
Hull University Teaching Hospitals NHS TrustCompleted
-
Boryung Pharmaceutical Co., LtdCompleted
-
Boehringer IngelheimCompleted
-
University of PalermoAstraZeneca; University of CataniaUnknown
-
Merck Sharp & Dohme LLCCompleted
-
SanofiCompletedType 2 Diabetes MellitusBrazil, Peru, United States, Australia, Canada, Chile, Germany, Guatemala, Mexico, Poland, Romania, Russian Federation, Ukraine
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Canada, Thailand, Korea, Republic of, United Kingdom, China, Germany, Israel, Mexico, Argentina, Brazil, Colombia, Puerto Rico, Russian Federation
-
Merck Sharp & Dohme LLCCompleted
-
University Magna GraeciaCompletedPolycystic Ovary Syndrome
-
Fundación Pública Andaluza para la gestión de la...AstraZenecaCompletedDiabetes Mellitus, Type 2Spain
-
Kaiser PermanentePatient-Centered Outcomes Research Institute; Henry Ford Health System; HealthPartners... and other collaboratorsRecruitingCardiovascular Diseases | Type 2 Diabetes MellitusUnited States